ARALEZ PHARMACEUTICALS INC. Accounts Receivable
ARALEZ PHARMACEUTICALS INC. had Accounts Receivable of $40.68 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2018-05-08
- 2018-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $40.68M.
- 2017-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $13.45M.
- 2017-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $11.34M.
- 2017-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $9.55M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2018-03-31 | $40.68M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $13.45M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $11.34M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $9.55M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $9.05M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $20.41M 10-K · filed 2018-03-14 |
| 2016-09-30 | $8.11M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $7.11M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $11.56M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $5.97M 10-K · filed 2017-03-13 |